VIII Symposium "Design, Obtaining and Development of Drugs" "SICF"

VIII International Symposium on Chemistry and Pharmaceutical Sciences

SICF

VIII Symposium "Design, Obtaining and Development of Drugs"

alzheimer’s disease; mri contrast agent; gadolinium(iii) oxide nanoparticles; dota; amylovis® × enfermedad de alzheimer; agentes de contrastes para rmi; nanopartículas de óxido de gadolinio(iii); dota; amylovis® ×